ipilimumab,nivolumab
bms
['nivo', '/ipi', 'rcc,(-irccs),(-srcc),(-urcc)', 'ipilimumab', 'nivolumab', 'renal,(-adrenal)', 'titan-rcc']
efficacy of a tailored approach with nivolumab and nivolumab/ipilimumab as an immunotherapeutic boost in metastatic #renalcellcarcinoma. final results of #titan-rcc. presented by . #esmo22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology